C. Kramers
Affiliations: |
Google:
"C. Kramers"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Huijbers MJ, Wentink C, Lucassen PLBJ, et al. (2023) Supporting antidepressant discontinuation using mindfulness plus monitoring versus monitoring alone: A cluster randomized trial in general practice. Plos One. 18: e0290965 |
| Beek MWHv, Roukens M, Jacobs WCH, et al. (2018) Real-World Adverse Effects of Capecitabine Toxicity in an Elderly Population Drugs - Real World Outcomes. 5: 161-167 |
| van den Elsen GA, Tobben L, Ahmed AI, et al. (2016) Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial. Journal of Psychopharmacology (Oxford, England) |
| Rongen S, Kramers C, O'Mahony D, et al. (2015) Potentially inappropriate prescribing in older patients admitted to psychiatric hospital. International Journal of Geriatric Psychiatry |
| van den Elsen GA, Ahmed AI, Verkes RJ, et al. (2015) Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial. Neurology. 84: 2338-46 |
| Ahmed AI, van den Elsen GA, Colbers A, et al. (2015) Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia. Psychopharmacology. 232: 2587-95 |
| Bos JM, Bemt PMLAvd, Pot H, et al. (2015) Effect of Medication Review And Physician Training Programme On Drug Related Events In High Risk Surgical Patients (P-Review Study) Clinical Therapeutics. 37 |
| Ahmed AI, van den Elsen GA, Colbers A, et al. (2014) Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1475-82 |
| van den Elsen GA, Ahmed AI, Lammers M, et al. (2014) Efficacy and safety of medical cannabinoids in older subjects: a systematic review. Ageing Research Reviews. 14: 56-64 |
| Ahmed AI, Ali AN, Kramers C, et al. (2013) Neuropsychiatric adverse events of varenicline: a systematic review of published reports. Journal of Clinical Psychopharmacology. 33: 55-62 |